![\"Parkinson](\"https:\/\/biologistjournal.com\/\/tr\/wp-content\/uploads\/shared\/pills-3114364_1280.jpg\")
“`html<\/p>\n“`html<\/p>\n
Kab\u0131zl\u0131k, Parkinson hastalar\u0131n\u0131n b\u00fcy\u00fck bir k\u0131sm\u0131n\u0131 etkiliyor ve genellikle motor bozukluklar ortaya \u00e7\u0131kmadan \u00e7ok \u00f6nce ba\u015fl\u0131yor. Ya\u015fam kalitesini ciddi \u015fekilde bozan bu sorun, ba\u011f\u0131rsak mikrobiyotas\u0131n\u0131n dengesizli\u011fi ve ba\u011f\u0131rsa\u011f\u0131n do\u011fal olarak \u00fcretti\u011fi faydal\u0131 k\u0131sa zincirli ya\u011f asitlerinin azalmas\u0131yla ili\u015fkili olabilir.<\/p>\n
Yak\u0131n zamanda yap\u0131lan bir \u00e7al\u0131\u015fma, iki t\u00fcr besin takviyesinin bu semptom \u00fczerindeki etkisini de\u011ferlendirdi: 2-fukozillaktoz adl\u0131 bir prebiyotik ve k\u0131sa zincirli ya\u011f asitleri. Alt\u0131 ay boyunca 72 hasta, bunlardan birini, di\u011ferini veya ikisinin kombinasyonunu ald\u0131. Sonu\u00e7lar, prebiyoti\u011fin tek ba\u015f\u0131na kab\u0131zl\u0131\u011f\u0131n \u015fiddetini \u00f6nemli \u00f6l\u00e7\u00fcde azaltt\u0131\u011f\u0131n\u0131 g\u00f6steriyor. Ancak en iyi sonu\u00e7lar, her iki takviyenin birlikte kullan\u0131lmas\u0131yla elde edildi. Kat\u0131l\u0131mc\u0131lar, d\u0131\u015fk\u0131 k\u0131vam\u0131nda iyile\u015fme, g\u00fcnl\u00fck defekasyon giri\u015fim say\u0131s\u0131nda azalma ve bu sorunla ilgili ya\u015fam kalitesinde art\u0131\u015f g\u00f6zlemlediler.<\/p>\n
K\u0131sa zincirli ya\u011f asitleri, kal\u0131n ba\u011f\u0131rsaktaki g\u0131da liflerinin fermantasyonu sonucu olu\u015fan molek\u00fcllerdir. Ba\u011f\u0131rsak sa\u011fl\u0131\u011f\u0131nda, ba\u011f\u0131rsa\u011f\u0131n koruyucu bariyerini g\u00fc\u00e7lendirerek ve iltihab\u0131 d\u00fczenleyerek kilit bir rol oynarlar. 2-fukozillaktoz ise, bifidobakteriler gibi faydal\u0131 ba\u011f\u0131rsak bakterilerinin b\u00fcy\u00fcmesini te\u015fvik eden ve bu ya\u011f asitlerini \u00fcreten karma\u015f\u0131k bir \u015fekerdir.<\/p>\n
D\u00fc\u015f\u00fcn\u00fclenden farkl\u0131 olarak, d\u0131\u015fk\u0131 s\u0131kl\u0131\u011f\u0131ndaki azalma her zaman kab\u0131zl\u0131\u011f\u0131n k\u00f6t\u00fcle\u015fmesi anlam\u0131na gelmez. Bu \u00e7al\u0131\u015fmada, kombine tedavi alan hastalar\u0131n g\u00fcnl\u00fck defekasyon say\u0131s\u0131 ikiden birine d\u00fc\u015ft\u00fc. Bunun nedeni, d\u0131\u015fk\u0131lar\u0131n daha tam ve tatmin edici hale gelmesi, b\u00f6ylece tekrarlayan ve ba\u015far\u0131s\u0131z giri\u015fim ihtiyac\u0131n\u0131 azaltmas\u0131d\u0131r. Kat\u0131l\u0131mc\u0131lar ayr\u0131ca a\u015f\u0131r\u0131 \u00e7abalar\u0131n azald\u0131\u011f\u0131n\u0131 ve bo\u015falt\u0131m\u0131n daha etkili oldu\u011funu bildirdiler.<\/p>\n
T\u00fcm gruplarda hastalar\u0131n ya\u015fam kalitesi iyile\u015fti, ancak kombine tedaviyle faydalar daha belirgindi. Bu, fiziksel a\u00e7\u0131dan m\u00fctevaz\u0131 iyile\u015fmelerin bile g\u00fcnl\u00fck refah \u00fczerinde \u00f6nemli bir etki yaratabilece\u011fini g\u00f6steriyor. Ara\u015ft\u0131rmac\u0131lar, bu sonu\u00e7lar\u0131n Parkinson hastal\u0131\u011f\u0131na ba\u011fl\u0131 sindirim semptomlar\u0131n\u0131 hafifletmek i\u00e7in ba\u011f\u0131rsak mikrobiyotas\u0131n\u0131 hedef alan yeni tedavi yakla\u015f\u0131mlar\u0131n\u0131n yolunu a\u00e7abilece\u011fini vurguluyor.<\/p>\n
\u00c7al\u0131\u015fma s\u00fcresince kat\u0131l\u0131mc\u0131lar\u0131n fiziksel aktivitelerinde herhangi bir de\u011fi\u015fiklik olmad\u0131, bu da g\u00f6zlemlenen iyile\u015fmelerin takviyelere atfedilebilece\u011fini ve d\u0131\u015f etkenlerden kaynaklanmad\u0131\u011f\u0131n\u0131 do\u011fruluyor. Bildirilen yan etkiler, hafif sindirim rahats\u0131zl\u0131klar\u0131 veya \u015fi\u015fkinlik gibi, minimal d\u00fczeyde kald\u0131 ve tedavinin devam\u0131n\u0131 engellemedi.<\/p>\n
Bu yakla\u015f\u0131m, uzun s\u00fcreli kullan\u0131m\u0131nda s\u0131v\u0131 dengesizlikleri, kolik \u00fclserler veya ba\u011f\u0131rsak iltihaplar\u0131na yol a\u00e7abilen laksatiflere g\u00fcvenli bir alternatif olabilir. Kab\u0131zl\u0131\u011f\u0131n altta yatan mekanizmalar\u0131n\u0131 do\u011frudan hedef alarak, bu takviyeler, geleneksel tedavilerle s\u0131k s\u0131k ili\u015fkilendirilen istenmeyen etkiler olmaks\u0131z\u0131n hastalar\u0131n konforunu art\u0131rmak i\u00e7in umut verici bir \u00e7\u00f6z\u00fcm sunuyor.<\/p>\n
“`<\/p>\n
DOI\u00a0:<\/strong> https:\/\/doi.org\/10.1007\/s40120-026-00972-6<\/a><\/p>\n Titre\u00a0:<\/strong> Prebiotics and SCFA Alleviate Parkinson\u2019s-Related Constipation: Results from a Randomized Controlled Trial<\/p>\n Revue : <\/strong> Neurology and Therapy<\/p>\n \u00c9diteur : <\/strong> Springer Science and Business Media LLC<\/p>\n Auteurs : <\/strong> Tobias Hegelmaier; Alexander Duscha; Christiane Desel; Lisa-Marie W\u00fcrtele; Jana Peplinski; Diana Jauk; Riccardo Troisi; Martin Klietz; Simon Faissner; Thomas M\u00fcller; Aiden Haghikia<\/p>\n","protected":false},"excerpt":{"rendered":" “`html Parkinson hastal\u0131\u011f\u0131na ba\u011fl\u0131 kab\u0131zl\u0131kta besin takviyeleri iyile\u015fme sa\u011fl\u0131yor Kab\u0131zl\u0131k, Parkinson hastalar\u0131n\u0131n b\u00fcy\u00fck bir k\u0131sm\u0131n\u0131 etkiliyor ve genellikle motor bozukluklar ortaya \u00e7\u0131kmadan \u00e7ok \u00f6nce ba\u015fl\u0131yor. Ya\u015fam kalitesini ciddi \u015fekilde bozan bu sorun, ba\u011f\u0131rsak mikrobiyotas\u0131n\u0131n dengesizli\u011fi ve ba\u011f\u0131rsa\u011f\u0131n do\u011fal olarak \u00fcretti\u011fi faydal\u0131 k\u0131sa zincirli ya\u011f asitlerinin azalmas\u0131yla ili\u015fkili olabilir. Yak\u0131n zamanda yap\u0131lan bir \u00e7al\u0131\u015fma, iki t\u00fcr… Okumaya devam et Parkinson hastal\u0131\u011f\u0131na ba\u011fl\u0131 kab\u0131zl\u0131kta besin takviyeleri iyile\u015fme sa\u011fl\u0131yor<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2,8],"tags":[],"class_list":["post-25","post","type-post","status-publish","format-standard","hentry","category-saglik","category-toplum","entry"],"_links":{"self":[{"href":"https:\/\/biologistjournal.com\/tr\/wp-json\/wp\/v2\/posts\/25","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biologistjournal.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biologistjournal.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biologistjournal.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/biologistjournal.com\/tr\/wp-json\/wp\/v2\/comments?post=25"}],"version-history":[{"count":1,"href":"https:\/\/biologistjournal.com\/tr\/wp-json\/wp\/v2\/posts\/25\/revisions"}],"predecessor-version":[{"id":26,"href":"https:\/\/biologistjournal.com\/tr\/wp-json\/wp\/v2\/posts\/25\/revisions\/26"}],"wp:attachment":[{"href":"https:\/\/biologistjournal.com\/tr\/wp-json\/wp\/v2\/media?parent=25"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biologistjournal.com\/tr\/wp-json\/wp\/v2\/categories?post=25"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biologistjournal.com\/tr\/wp-json\/wp\/v2\/tags?post=25"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}